|
Centre for Policy on Ageing | |
 | |
|
Treatment for the secondary prevention of stroke in older patients the influence of dementia status | Author(s) | Joan T Moroney, Chin-Lin Tseng, Myunghee C Paik |
Journal title | Journal of the American Geriatrics Society, vol 47, no 7, July 1999 |
Pages | pp 824-829 |
Keywords | Stroke ; Drugs ; Preventative medicine ; Dementia ; Clinical surveys. |
Annotation | Based on examinations and medical record review of 272 patients (mean age 72.1 years), the authors investigated the frequency of aspirin and /or warfarin use at hospital discharge for the prevention of recurrent stroke in older patients with acute ischaemic stroke. 31 patients (11.4%) were not prescribed aspirin or warfarin at hospital discharge. Logistic regression determined that dementia was a significant independent determinant of non-treatment with aspirin or warfarin, adjusting for: abnormal gait; discharge to a nursing or residential home; cardiac disease; cortical infarct location; age 80 and over; and age 70 79 versus age 60-69. The results suggest that dementia is a significant independent determinant of non-treatment with aspirin or warfarin indicated for the prevention of recurrent stroke. The under-utilisation of aspirin and warfarin in older stroke patients with dementia may be a modifiable basis for their increased risk of recurrence and death. (RH). |
Accession Number | CPA-990825317 A |
Classmark | CQA: LLD: LK2: EA: 3G |
Data © Centre for Policy on Ageing |
|
...from the Ageinfo database published by Centre for Policy on Ageing. |
| |
|